Stock ENTA ENANTA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Real-time Estimate Cboe BZX
Other stock markets
 17:29:48 03/05/2024 BST 		5-day change 1st Jan Change
14.74 USD +5.93% Intraday chart for Enanta Pharmaceuticals, Inc. +19.68% +57.33%
04-30 Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer CI
02-09 Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Enanta Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
BU
Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer
CI
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
BU
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
BU
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
BU
Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating
MT
Transcript : Enanta Pharmaceuticals, Inc., Q1 2024 Earnings Call, Feb 07, 2024
Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Reports Q1 Revenue $18M, vs. Street Est of $21.9M
MT
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot
AQ
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
BU
Enanta Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
BU
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
BU
Transcript : Enanta Pharmaceuticals, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 09:45 AM
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
BU
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BU
Enanta Pharmaceuticals, Inc. Announces Retirement of Nathaniel S. Gardiner as Senior Vice President and General Counsel, Effective on or Before March 31, 2024
CI
Enanta Pharmaceuticals, Inc.(NasdaqGS:ENTA) dropped from NASDAQ Biotechnology Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENTA Stock
  4. News Enanta Pharmaceuticals, Inc.